{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Caguas",
      "state": "PR",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "76020",
      "recalling_firm": "Mylan LLC.",
      "address_1": "Road #156, Km. 58.8, Lot 24B",
      "address_2": "N/A",
      "postal_code": "00725",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "N/A",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0442-2017",
      "product_description": "Temozolomide Capsules, 140 mg, packaged in a) 5-count bottles (NDC 0378-5263-98), b) 14-count bottles (NDC 0378-5263-14), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA.",
      "product_quantity": "a) 746 bottles (lot 2006903); b)588 bottles (lot 2006902)",
      "reason_for_recall": "Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.",
      "recall_initiation_date": "20161220",
      "center_classification_date": "20170125",
      "termination_date": "20180125",
      "report_date": "20170201",
      "code_info": "LOT #: a) 2006903, Exp 02/18; b) 2006902, Exp 02/18"
    }
  ]
}